Global Cell and Gene Therapy Supply Chain and Logistics Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Cell and Gene Therapy Supply Chain and Logistics market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Cell and Gene Therapy Supply Chain and Logistics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and By Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Cell and Gene Therapy Supply Chain and Logistics market size and forecasts, in consumption value ($ Million), 2018-2029
Global Cell and Gene Therapy Supply Chain and Logistics market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Cell and Gene Therapy Supply Chain and Logistics market size and forecasts, by Type and By Application, in consumption value ($ Million), 2018-2029
Global Cell and Gene Therapy Supply Chain and Logistics market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cell and Gene Therapy Supply Chain and Logistics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cell and Gene Therapy Supply Chain and Logistics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Be The Match BioTherapies, Biocair, Marken, World Courier and MAK-SYSTEM, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Cell and Gene Therapy Supply Chain and Logistics market is split by Type and By Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and By Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Cell and Gene Therapy Supply Chain and Logistics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell and Gene Therapy Supply Chain and Logistics, with revenue, gross margin and global market share of Cell and Gene Therapy Supply Chain and Logistics from 2018 to 2023.
Chapter 3, the Cell and Gene Therapy Supply Chain and Logistics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Cell and Gene Therapy Supply Chain and Logistics market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell and Gene Therapy Supply Chain and Logistics.
Chapter 13, to describe Cell and Gene Therapy Supply Chain and Logistics research findings and conclusion.
This report is a detailed and comprehensive analysis for global Cell and Gene Therapy Supply Chain and Logistics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and By Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Cell and Gene Therapy Supply Chain and Logistics market size and forecasts, in consumption value ($ Million), 2018-2029
Global Cell and Gene Therapy Supply Chain and Logistics market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Cell and Gene Therapy Supply Chain and Logistics market size and forecasts, by Type and By Application, in consumption value ($ Million), 2018-2029
Global Cell and Gene Therapy Supply Chain and Logistics market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cell and Gene Therapy Supply Chain and Logistics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cell and Gene Therapy Supply Chain and Logistics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Be The Match BioTherapies, Biocair, Marken, World Courier and MAK-SYSTEM, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Cell and Gene Therapy Supply Chain and Logistics market is split by Type and By Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and By Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Ordering and Scheduling Services
- Sample Collection Services
- Logistics Services
- Post Treatment Follow-Up Services
- Biobank
- Cell Therapy Lab
- Hospital
- Research Institute
- Be The Match BioTherapies
- Biocair
- Marken
- World Courier
- MAK-SYSTEM
- Cryoport
- Brooks Life Sciences
- Clarkston Consulting
- Hypertrust Patient Data Care
- Haemonetics
- MasterControl
- TraceLink
- SAVSU Technologies
- TrakCel
- Title21 Health Solutions
- sedApta Group
- Vineti
- Stafa Cellular Therapy
- Thermo Fisher Scientific
- McKesson
- BioLife Solutions
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Cell and Gene Therapy Supply Chain and Logistics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell and Gene Therapy Supply Chain and Logistics, with revenue, gross margin and global market share of Cell and Gene Therapy Supply Chain and Logistics from 2018 to 2023.
Chapter 3, the Cell and Gene Therapy Supply Chain and Logistics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Cell and Gene Therapy Supply Chain and Logistics market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell and Gene Therapy Supply Chain and Logistics.
Chapter 13, to describe Cell and Gene Therapy Supply Chain and Logistics research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Cell and Gene Therapy Supply Chain and Logistics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cell and Gene Therapy Supply Chain and Logistics by Type
1.3.1 Overview: Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type in 2022
1.3.3 Ordering and Scheduling Services
1.3.4 Sample Collection Services
1.3.5 Logistics Services
1.3.6 Post Treatment Follow-Up Services
1.4 Global Cell and Gene Therapy Supply Chain and Logistics Market By Application
1.4.1 Overview: Global Cell and Gene Therapy Supply Chain and Logistics Market Size By Application: 2018 Versus 2022 Versus 2029
1.4.2 Biobank
1.4.3 Cell Therapy Lab
1.4.4 Hospital
1.4.5 Research Institute
1.5 Global Cell and Gene Therapy Supply Chain and Logistics Market Size & Forecast
1.6 Global Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast by Region
1.6.1 Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Region, (2018-2029)
1.6.3 North America Cell and Gene Therapy Supply Chain and Logistics Market Size and Prospect (2018-2029)
1.6.4 Europe Cell and Gene Therapy Supply Chain and Logistics Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Market Size and Prospect (2018-2029)
1.6.6 South America Cell and Gene Therapy Supply Chain and Logistics Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Cell and Gene Therapy Supply Chain and Logistics Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Be The Match BioTherapies
2.1.1 Be The Match BioTherapies Details
2.1.2 Be The Match BioTherapies Major Business
2.1.3 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.1.4 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Be The Match BioTherapies Recent Developments and Future Plans
2.2 Biocair
2.2.1 Biocair Details
2.2.2 Biocair Major Business
2.2.3 Biocair Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.2.4 Biocair Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Biocair Recent Developments and Future Plans
2.3 Marken
2.3.1 Marken Details
2.3.2 Marken Major Business
2.3.3 Marken Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.3.4 Marken Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Marken Recent Developments and Future Plans
2.4 World Courier
2.4.1 World Courier Details
2.4.2 World Courier Major Business
2.4.3 World Courier Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.4.4 World Courier Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 World Courier Recent Developments and Future Plans
2.5 MAK-SYSTEM
2.5.1 MAK-SYSTEM Details
2.5.2 MAK-SYSTEM Major Business
2.5.3 MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.5.4 MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 MAK-SYSTEM Recent Developments and Future Plans
2.6 Cryoport
2.6.1 Cryoport Details
2.6.2 Cryoport Major Business
2.6.3 Cryoport Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.6.4 Cryoport Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Cryoport Recent Developments and Future Plans
2.7 Brooks Life Sciences
2.7.1 Brooks Life Sciences Details
2.7.2 Brooks Life Sciences Major Business
2.7.3 Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.7.4 Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Brooks Life Sciences Recent Developments and Future Plans
2.8 Clarkston Consulting
2.8.1 Clarkston Consulting Details
2.8.2 Clarkston Consulting Major Business
2.8.3 Clarkston Consulting Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.8.4 Clarkston Consulting Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Clarkston Consulting Recent Developments and Future Plans
2.9 Hypertrust Patient Data Care
2.9.1 Hypertrust Patient Data Care Details
2.9.2 Hypertrust Patient Data Care Major Business
2.9.3 Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.9.4 Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Hypertrust Patient Data Care Recent Developments and Future Plans
2.10 Haemonetics
2.10.1 Haemonetics Details
2.10.2 Haemonetics Major Business
2.10.3 Haemonetics Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.10.4 Haemonetics Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Haemonetics Recent Developments and Future Plans
2.11 MasterControl
2.11.1 MasterControl Details
2.11.2 MasterControl Major Business
2.11.3 MasterControl Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.11.4 MasterControl Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 MasterControl Recent Developments and Future Plans
2.12 TraceLink
2.12.1 TraceLink Details
2.12.2 TraceLink Major Business
2.12.3 TraceLink Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.12.4 TraceLink Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 TraceLink Recent Developments and Future Plans
2.13 SAVSU Technologies
2.13.1 SAVSU Technologies Details
2.13.2 SAVSU Technologies Major Business
2.13.3 SAVSU Technologies Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.13.4 SAVSU Technologies Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 SAVSU Technologies Recent Developments and Future Plans
2.14 TrakCel
2.14.1 TrakCel Details
2.14.2 TrakCel Major Business
2.14.3 TrakCel Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.14.4 TrakCel Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 TrakCel Recent Developments and Future Plans
2.15 Title21 Health Solutions
2.15.1 Title21 Health Solutions Details
2.15.2 Title21 Health Solutions Major Business
2.15.3 Title21 Health Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.15.4 Title21 Health Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Title21 Health Solutions Recent Developments and Future Plans
2.16 sedApta Group
2.16.1 sedApta Group Details
2.16.2 sedApta Group Major Business
2.16.3 sedApta Group Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.16.4 sedApta Group Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 sedApta Group Recent Developments and Future Plans
2.17 Vineti
2.17.1 Vineti Details
2.17.2 Vineti Major Business
2.17.3 Vineti Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.17.4 Vineti Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Vineti Recent Developments and Future Plans
2.18 Stafa Cellular Therapy
2.18.1 Stafa Cellular Therapy Details
2.18.2 Stafa Cellular Therapy Major Business
2.18.3 Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.18.4 Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Stafa Cellular Therapy Recent Developments and Future Plans
2.19 Thermo Fisher Scientific
2.19.1 Thermo Fisher Scientific Details
2.19.2 Thermo Fisher Scientific Major Business
2.19.3 Thermo Fisher Scientific Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.19.4 Thermo Fisher Scientific Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.20 McKesson
2.20.1 McKesson Details
2.20.2 McKesson Major Business
2.20.3 McKesson Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.20.4 McKesson Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 McKesson Recent Developments and Future Plans
2.21 BioLife Solutions
2.21.1 BioLife Solutions Details
2.21.2 BioLife Solutions Major Business
2.21.3 BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.21.4 BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 BioLife Solutions Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Cell and Gene Therapy Supply Chain and Logistics Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Cell and Gene Therapy Supply Chain and Logistics by Company Revenue
3.2.2 Top 3 Cell and Gene Therapy Supply Chain and Logistics Players Market Share in 2022
3.2.3 Top 6 Cell and Gene Therapy Supply Chain and Logistics Players Market Share in 2022
3.3 Cell and Gene Therapy Supply Chain and Logistics Market: Overall Company Footprint Analysis
3.3.1 Cell and Gene Therapy Supply Chain and Logistics Market: Region Footprint
3.3.2 Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Type Footprint
3.3.3 Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value and Market Share by Type (2018-2023)
4.2 Global Cell and Gene Therapy Supply Chain and Logistics Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share By Application (2018-2023)
5.2 Global Cell and Gene Therapy Supply Chain and Logistics Market Forecast By Application (2024-2029)
6 NORTH AMERICA
6.1 North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2018-2029)
6.2 North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value By Application (2018-2029)
6.3 North America Cell and Gene Therapy Supply Chain and Logistics Market Size by Country
6.3.1 North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2018-2029)
6.3.2 United States Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
6.3.3 Canada Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
6.3.4 Mexico Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2018-2029)
7.2 Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value By Application (2018-2029)
7.3 Europe Cell and Gene Therapy Supply Chain and Logistics Market Size by Country
7.3.1 Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2018-2029)
7.3.2 Germany Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
7.3.3 France Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
7.3.5 Russia Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
7.3.6 Italy Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value By Application (2018-2029)
8.3 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Market Size by Region
8.3.1 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2018-2029)
8.3.2 China Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
8.3.3 Japan Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
8.3.4 South Korea Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
8.3.5 India Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
8.3.7 Australia Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2018-2029)
9.2 South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value By Application (2018-2029)
9.3 South America Cell and Gene Therapy Supply Chain and Logistics Market Size by Country
9.3.1 South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2018-2029)
9.3.2 Brazil Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
9.3.3 Argentina Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value By Application (2018-2029)
10.3 Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size by Country
10.3.1 Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2018-2029)
10.3.2 Turkey Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
10.3.4 UAE Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Cell and Gene Therapy Supply Chain and Logistics Market Drivers
11.2 Cell and Gene Therapy Supply Chain and Logistics Market Restraints
11.3 Cell and Gene Therapy Supply Chain and Logistics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Cell and Gene Therapy Supply Chain and Logistics Industry Chain
12.2 Cell and Gene Therapy Supply Chain and Logistics Upstream Analysis
12.3 Cell and Gene Therapy Supply Chain and Logistics Midstream Analysis
12.4 Cell and Gene Therapy Supply Chain and Logistics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Cell and Gene Therapy Supply Chain and Logistics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cell and Gene Therapy Supply Chain and Logistics by Type
1.3.1 Overview: Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type in 2022
1.3.3 Ordering and Scheduling Services
1.3.4 Sample Collection Services
1.3.5 Logistics Services
1.3.6 Post Treatment Follow-Up Services
1.4 Global Cell and Gene Therapy Supply Chain and Logistics Market By Application
1.4.1 Overview: Global Cell and Gene Therapy Supply Chain and Logistics Market Size By Application: 2018 Versus 2022 Versus 2029
1.4.2 Biobank
1.4.3 Cell Therapy Lab
1.4.4 Hospital
1.4.5 Research Institute
1.5 Global Cell and Gene Therapy Supply Chain and Logistics Market Size & Forecast
1.6 Global Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast by Region
1.6.1 Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Region, (2018-2029)
1.6.3 North America Cell and Gene Therapy Supply Chain and Logistics Market Size and Prospect (2018-2029)
1.6.4 Europe Cell and Gene Therapy Supply Chain and Logistics Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Market Size and Prospect (2018-2029)
1.6.6 South America Cell and Gene Therapy Supply Chain and Logistics Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Cell and Gene Therapy Supply Chain and Logistics Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Be The Match BioTherapies
2.1.1 Be The Match BioTherapies Details
2.1.2 Be The Match BioTherapies Major Business
2.1.3 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.1.4 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Be The Match BioTherapies Recent Developments and Future Plans
2.2 Biocair
2.2.1 Biocair Details
2.2.2 Biocair Major Business
2.2.3 Biocair Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.2.4 Biocair Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Biocair Recent Developments and Future Plans
2.3 Marken
2.3.1 Marken Details
2.3.2 Marken Major Business
2.3.3 Marken Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.3.4 Marken Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Marken Recent Developments and Future Plans
2.4 World Courier
2.4.1 World Courier Details
2.4.2 World Courier Major Business
2.4.3 World Courier Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.4.4 World Courier Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 World Courier Recent Developments and Future Plans
2.5 MAK-SYSTEM
2.5.1 MAK-SYSTEM Details
2.5.2 MAK-SYSTEM Major Business
2.5.3 MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.5.4 MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 MAK-SYSTEM Recent Developments and Future Plans
2.6 Cryoport
2.6.1 Cryoport Details
2.6.2 Cryoport Major Business
2.6.3 Cryoport Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.6.4 Cryoport Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Cryoport Recent Developments and Future Plans
2.7 Brooks Life Sciences
2.7.1 Brooks Life Sciences Details
2.7.2 Brooks Life Sciences Major Business
2.7.3 Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.7.4 Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Brooks Life Sciences Recent Developments and Future Plans
2.8 Clarkston Consulting
2.8.1 Clarkston Consulting Details
2.8.2 Clarkston Consulting Major Business
2.8.3 Clarkston Consulting Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.8.4 Clarkston Consulting Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Clarkston Consulting Recent Developments and Future Plans
2.9 Hypertrust Patient Data Care
2.9.1 Hypertrust Patient Data Care Details
2.9.2 Hypertrust Patient Data Care Major Business
2.9.3 Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.9.4 Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Hypertrust Patient Data Care Recent Developments and Future Plans
2.10 Haemonetics
2.10.1 Haemonetics Details
2.10.2 Haemonetics Major Business
2.10.3 Haemonetics Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.10.4 Haemonetics Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Haemonetics Recent Developments and Future Plans
2.11 MasterControl
2.11.1 MasterControl Details
2.11.2 MasterControl Major Business
2.11.3 MasterControl Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.11.4 MasterControl Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 MasterControl Recent Developments and Future Plans
2.12 TraceLink
2.12.1 TraceLink Details
2.12.2 TraceLink Major Business
2.12.3 TraceLink Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.12.4 TraceLink Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 TraceLink Recent Developments and Future Plans
2.13 SAVSU Technologies
2.13.1 SAVSU Technologies Details
2.13.2 SAVSU Technologies Major Business
2.13.3 SAVSU Technologies Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.13.4 SAVSU Technologies Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 SAVSU Technologies Recent Developments and Future Plans
2.14 TrakCel
2.14.1 TrakCel Details
2.14.2 TrakCel Major Business
2.14.3 TrakCel Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.14.4 TrakCel Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 TrakCel Recent Developments and Future Plans
2.15 Title21 Health Solutions
2.15.1 Title21 Health Solutions Details
2.15.2 Title21 Health Solutions Major Business
2.15.3 Title21 Health Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.15.4 Title21 Health Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Title21 Health Solutions Recent Developments and Future Plans
2.16 sedApta Group
2.16.1 sedApta Group Details
2.16.2 sedApta Group Major Business
2.16.3 sedApta Group Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.16.4 sedApta Group Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 sedApta Group Recent Developments and Future Plans
2.17 Vineti
2.17.1 Vineti Details
2.17.2 Vineti Major Business
2.17.3 Vineti Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.17.4 Vineti Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Vineti Recent Developments and Future Plans
2.18 Stafa Cellular Therapy
2.18.1 Stafa Cellular Therapy Details
2.18.2 Stafa Cellular Therapy Major Business
2.18.3 Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.18.4 Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Stafa Cellular Therapy Recent Developments and Future Plans
2.19 Thermo Fisher Scientific
2.19.1 Thermo Fisher Scientific Details
2.19.2 Thermo Fisher Scientific Major Business
2.19.3 Thermo Fisher Scientific Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.19.4 Thermo Fisher Scientific Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.20 McKesson
2.20.1 McKesson Details
2.20.2 McKesson Major Business
2.20.3 McKesson Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.20.4 McKesson Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 McKesson Recent Developments and Future Plans
2.21 BioLife Solutions
2.21.1 BioLife Solutions Details
2.21.2 BioLife Solutions Major Business
2.21.3 BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.21.4 BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 BioLife Solutions Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Cell and Gene Therapy Supply Chain and Logistics Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Cell and Gene Therapy Supply Chain and Logistics by Company Revenue
3.2.2 Top 3 Cell and Gene Therapy Supply Chain and Logistics Players Market Share in 2022
3.2.3 Top 6 Cell and Gene Therapy Supply Chain and Logistics Players Market Share in 2022
3.3 Cell and Gene Therapy Supply Chain and Logistics Market: Overall Company Footprint Analysis
3.3.1 Cell and Gene Therapy Supply Chain and Logistics Market: Region Footprint
3.3.2 Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Type Footprint
3.3.3 Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value and Market Share by Type (2018-2023)
4.2 Global Cell and Gene Therapy Supply Chain and Logistics Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share By Application (2018-2023)
5.2 Global Cell and Gene Therapy Supply Chain and Logistics Market Forecast By Application (2024-2029)
6 NORTH AMERICA
6.1 North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2018-2029)
6.2 North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value By Application (2018-2029)
6.3 North America Cell and Gene Therapy Supply Chain and Logistics Market Size by Country
6.3.1 North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2018-2029)
6.3.2 United States Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
6.3.3 Canada Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
6.3.4 Mexico Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2018-2029)
7.2 Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value By Application (2018-2029)
7.3 Europe Cell and Gene Therapy Supply Chain and Logistics Market Size by Country
7.3.1 Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2018-2029)
7.3.2 Germany Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
7.3.3 France Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
7.3.5 Russia Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
7.3.6 Italy Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value By Application (2018-2029)
8.3 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Market Size by Region
8.3.1 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2018-2029)
8.3.2 China Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
8.3.3 Japan Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
8.3.4 South Korea Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
8.3.5 India Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
8.3.7 Australia Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2018-2029)
9.2 South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value By Application (2018-2029)
9.3 South America Cell and Gene Therapy Supply Chain and Logistics Market Size by Country
9.3.1 South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2018-2029)
9.3.2 Brazil Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
9.3.3 Argentina Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value By Application (2018-2029)
10.3 Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size by Country
10.3.1 Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2018-2029)
10.3.2 Turkey Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
10.3.4 UAE Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Cell and Gene Therapy Supply Chain and Logistics Market Drivers
11.2 Cell and Gene Therapy Supply Chain and Logistics Market Restraints
11.3 Cell and Gene Therapy Supply Chain and Logistics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Cell and Gene Therapy Supply Chain and Logistics Industry Chain
12.2 Cell and Gene Therapy Supply Chain and Logistics Upstream Analysis
12.3 Cell and Gene Therapy Supply Chain and Logistics Midstream Analysis
12.4 Cell and Gene Therapy Supply Chain and Logistics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value By Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Be The Match BioTherapies Company Information, Head Office, and Major Competitors
Table 6. Be The Match BioTherapies Major Business
Table 7. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 8. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Be The Match BioTherapies Recent Developments and Future Plans
Table 10. Biocair Company Information, Head Office, and Major Competitors
Table 11. Biocair Major Business
Table 12. Biocair Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 13. Biocair Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Biocair Recent Developments and Future Plans
Table 15. Marken Company Information, Head Office, and Major Competitors
Table 16. Marken Major Business
Table 17. Marken Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 18. Marken Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Marken Recent Developments and Future Plans
Table 20. World Courier Company Information, Head Office, and Major Competitors
Table 21. World Courier Major Business
Table 22. World Courier Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 23. World Courier Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. World Courier Recent Developments and Future Plans
Table 25. MAK-SYSTEM Company Information, Head Office, and Major Competitors
Table 26. MAK-SYSTEM Major Business
Table 27. MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 28. MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. MAK-SYSTEM Recent Developments and Future Plans
Table 30. Cryoport Company Information, Head Office, and Major Competitors
Table 31. Cryoport Major Business
Table 32. Cryoport Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 33. Cryoport Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Cryoport Recent Developments and Future Plans
Table 35. Brooks Life Sciences Company Information, Head Office, and Major Competitors
Table 36. Brooks Life Sciences Major Business
Table 37. Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 38. Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Brooks Life Sciences Recent Developments and Future Plans
Table 40. Clarkston Consulting Company Information, Head Office, and Major Competitors
Table 41. Clarkston Consulting Major Business
Table 42. Clarkston Consulting Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 43. Clarkston Consulting Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Clarkston Consulting Recent Developments and Future Plans
Table 45. Hypertrust Patient Data Care Company Information, Head Office, and Major Competitors
Table 46. Hypertrust Patient Data Care Major Business
Table 47. Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 48. Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Hypertrust Patient Data Care Recent Developments and Future Plans
Table 50. Haemonetics Company Information, Head Office, and Major Competitors
Table 51. Haemonetics Major Business
Table 52. Haemonetics Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 53. Haemonetics Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Haemonetics Recent Developments and Future Plans
Table 55. MasterControl Company Information, Head Office, and Major Competitors
Table 56. MasterControl Major Business
Table 57. MasterControl Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 58. MasterControl Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. MasterControl Recent Developments and Future Plans
Table 60. TraceLink Company Information, Head Office, and Major Competitors
Table 61. TraceLink Major Business
Table 62. TraceLink Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 63. TraceLink Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. TraceLink Recent Developments and Future Plans
Table 65. SAVSU Technologies Company Information, Head Office, and Major Competitors
Table 66. SAVSU Technologies Major Business
Table 67. SAVSU Technologies Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 68. SAVSU Technologies Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. SAVSU Technologies Recent Developments and Future Plans
Table 70. TrakCel Company Information, Head Office, and Major Competitors
Table 71. TrakCel Major Business
Table 72. TrakCel Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 73. TrakCel Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. TrakCel Recent Developments and Future Plans
Table 75. Title21 Health Solutions Company Information, Head Office, and Major Competitors
Table 76. Title21 Health Solutions Major Business
Table 77. Title21 Health Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 78. Title21 Health Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Title21 Health Solutions Recent Developments and Future Plans
Table 80. sedApta Group Company Information, Head Office, and Major Competitors
Table 81. sedApta Group Major Business
Table 82. sedApta Group Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 83. sedApta Group Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. sedApta Group Recent Developments and Future Plans
Table 85. Vineti Company Information, Head Office, and Major Competitors
Table 86. Vineti Major Business
Table 87. Vineti Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 88. Vineti Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Vineti Recent Developments and Future Plans
Table 90. Stafa Cellular Therapy Company Information, Head Office, and Major Competitors
Table 91. Stafa Cellular Therapy Major Business
Table 92. Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 93. Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Stafa Cellular Therapy Recent Developments and Future Plans
Table 95. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 96. Thermo Fisher Scientific Major Business
Table 97. Thermo Fisher Scientific Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 98. Thermo Fisher Scientific Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Thermo Fisher Scientific Recent Developments and Future Plans
Table 100. McKesson Company Information, Head Office, and Major Competitors
Table 101. McKesson Major Business
Table 102. McKesson Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 103. McKesson Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. McKesson Recent Developments and Future Plans
Table 105. BioLife Solutions Company Information, Head Office, and Major Competitors
Table 106. BioLife Solutions Major Business
Table 107. BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 108. BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. BioLife Solutions Recent Developments and Future Plans
Table 110. Global Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million) by Players (2018-2023)
Table 111. Global Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Players (2018-2023)
Table 112. Breakdown of Cell and Gene Therapy Supply Chain and Logistics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 113. Market Position of Players in Cell and Gene Therapy Supply Chain and Logistics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 114. Head Office of Key Cell and Gene Therapy Supply Chain and Logistics Players
Table 115. Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Type Footprint
Table 116. Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Application Footprint
Table 117. Cell and Gene Therapy Supply Chain and Logistics New Market Entrants and Barriers to Market Entry
Table 118. Cell and Gene Therapy Supply Chain and Logistics Mergers, Acquisition, Agreements, and Collaborations
Table 119. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value (USD Million) by Type (2018-2023)
Table 120. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Share by Type (2018-2023)
Table 121. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Forecast by Type (2024-2029)
Table 122. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value By Application (2018-2023)
Table 123. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Forecast By Application (2024-2029)
Table 124. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2018-2023) & (USD Million)
Table 125. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2024-2029) & (USD Million)
Table 126. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value By Application (2018-2023) & (USD Million)
Table 127. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value By Application (2024-2029) & (USD Million)
Table 128. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2018-2023) & (USD Million)
Table 129. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2024-2029) & (USD Million)
Table 130. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2018-2023) & (USD Million)
Table 131. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2024-2029) & (USD Million)
Table 132. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value By Application (2018-2023) & (USD Million)
Table 133. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value By Application (2024-2029) & (USD Million)
Table 134. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2018-2023) & (USD Million)
Table 135. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2024-2029) & (USD Million)
Table 136. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2018-2023) & (USD Million)
Table 137. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2024-2029) & (USD Million)
Table 138. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value By Application (2018-2023) & (USD Million)
Table 139. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value By Application (2024-2029) & (USD Million)
Table 140. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2018-2023) & (USD Million)
Table 141. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2024-2029) & (USD Million)
Table 142. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2018-2023) & (USD Million)
Table 143. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2024-2029) & (USD Million)
Table 144. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value By Application (2018-2023) & (USD Million)
Table 145. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value By Application (2024-2029) & (USD Million)
Table 146. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2018-2023) & (USD Million)
Table 147. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2024-2029) & (USD Million)
Table 148. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2018-2023) & (USD Million)
Table 149. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2024-2029) & (USD Million)
Table 150. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value By Application (2018-2023) & (USD Million)
Table 151. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value By Application (2024-2029) & (USD Million)
Table 152. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2018-2023) & (USD Million)
Table 153. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2024-2029) & (USD Million)
Table 154. Cell and Gene Therapy Supply Chain and Logistics Raw Material
Table 155. Key Suppliers of Cell and Gene Therapy Supply Chain and Logistics Raw Materials
Table 1. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value By Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Be The Match BioTherapies Company Information, Head Office, and Major Competitors
Table 6. Be The Match BioTherapies Major Business
Table 7. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 8. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Be The Match BioTherapies Recent Developments and Future Plans
Table 10. Biocair Company Information, Head Office, and Major Competitors
Table 11. Biocair Major Business
Table 12. Biocair Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 13. Biocair Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Biocair Recent Developments and Future Plans
Table 15. Marken Company Information, Head Office, and Major Competitors
Table 16. Marken Major Business
Table 17. Marken Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 18. Marken Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Marken Recent Developments and Future Plans
Table 20. World Courier Company Information, Head Office, and Major Competitors
Table 21. World Courier Major Business
Table 22. World Courier Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 23. World Courier Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. World Courier Recent Developments and Future Plans
Table 25. MAK-SYSTEM Company Information, Head Office, and Major Competitors
Table 26. MAK-SYSTEM Major Business
Table 27. MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 28. MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. MAK-SYSTEM Recent Developments and Future Plans
Table 30. Cryoport Company Information, Head Office, and Major Competitors
Table 31. Cryoport Major Business
Table 32. Cryoport Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 33. Cryoport Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Cryoport Recent Developments and Future Plans
Table 35. Brooks Life Sciences Company Information, Head Office, and Major Competitors
Table 36. Brooks Life Sciences Major Business
Table 37. Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 38. Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Brooks Life Sciences Recent Developments and Future Plans
Table 40. Clarkston Consulting Company Information, Head Office, and Major Competitors
Table 41. Clarkston Consulting Major Business
Table 42. Clarkston Consulting Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 43. Clarkston Consulting Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Clarkston Consulting Recent Developments and Future Plans
Table 45. Hypertrust Patient Data Care Company Information, Head Office, and Major Competitors
Table 46. Hypertrust Patient Data Care Major Business
Table 47. Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 48. Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Hypertrust Patient Data Care Recent Developments and Future Plans
Table 50. Haemonetics Company Information, Head Office, and Major Competitors
Table 51. Haemonetics Major Business
Table 52. Haemonetics Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 53. Haemonetics Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Haemonetics Recent Developments and Future Plans
Table 55. MasterControl Company Information, Head Office, and Major Competitors
Table 56. MasterControl Major Business
Table 57. MasterControl Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 58. MasterControl Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. MasterControl Recent Developments and Future Plans
Table 60. TraceLink Company Information, Head Office, and Major Competitors
Table 61. TraceLink Major Business
Table 62. TraceLink Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 63. TraceLink Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. TraceLink Recent Developments and Future Plans
Table 65. SAVSU Technologies Company Information, Head Office, and Major Competitors
Table 66. SAVSU Technologies Major Business
Table 67. SAVSU Technologies Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 68. SAVSU Technologies Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. SAVSU Technologies Recent Developments and Future Plans
Table 70. TrakCel Company Information, Head Office, and Major Competitors
Table 71. TrakCel Major Business
Table 72. TrakCel Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 73. TrakCel Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. TrakCel Recent Developments and Future Plans
Table 75. Title21 Health Solutions Company Information, Head Office, and Major Competitors
Table 76. Title21 Health Solutions Major Business
Table 77. Title21 Health Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 78. Title21 Health Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Title21 Health Solutions Recent Developments and Future Plans
Table 80. sedApta Group Company Information, Head Office, and Major Competitors
Table 81. sedApta Group Major Business
Table 82. sedApta Group Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 83. sedApta Group Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. sedApta Group Recent Developments and Future Plans
Table 85. Vineti Company Information, Head Office, and Major Competitors
Table 86. Vineti Major Business
Table 87. Vineti Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 88. Vineti Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Vineti Recent Developments and Future Plans
Table 90. Stafa Cellular Therapy Company Information, Head Office, and Major Competitors
Table 91. Stafa Cellular Therapy Major Business
Table 92. Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 93. Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Stafa Cellular Therapy Recent Developments and Future Plans
Table 95. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 96. Thermo Fisher Scientific Major Business
Table 97. Thermo Fisher Scientific Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 98. Thermo Fisher Scientific Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Thermo Fisher Scientific Recent Developments and Future Plans
Table 100. McKesson Company Information, Head Office, and Major Competitors
Table 101. McKesson Major Business
Table 102. McKesson Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 103. McKesson Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. McKesson Recent Developments and Future Plans
Table 105. BioLife Solutions Company Information, Head Office, and Major Competitors
Table 106. BioLife Solutions Major Business
Table 107. BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 108. BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. BioLife Solutions Recent Developments and Future Plans
Table 110. Global Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million) by Players (2018-2023)
Table 111. Global Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Players (2018-2023)
Table 112. Breakdown of Cell and Gene Therapy Supply Chain and Logistics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 113. Market Position of Players in Cell and Gene Therapy Supply Chain and Logistics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 114. Head Office of Key Cell and Gene Therapy Supply Chain and Logistics Players
Table 115. Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Type Footprint
Table 116. Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Application Footprint
Table 117. Cell and Gene Therapy Supply Chain and Logistics New Market Entrants and Barriers to Market Entry
Table 118. Cell and Gene Therapy Supply Chain and Logistics Mergers, Acquisition, Agreements, and Collaborations
Table 119. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value (USD Million) by Type (2018-2023)
Table 120. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Share by Type (2018-2023)
Table 121. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Forecast by Type (2024-2029)
Table 122. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value By Application (2018-2023)
Table 123. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Forecast By Application (2024-2029)
Table 124. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2018-2023) & (USD Million)
Table 125. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2024-2029) & (USD Million)
Table 126. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value By Application (2018-2023) & (USD Million)
Table 127. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value By Application (2024-2029) & (USD Million)
Table 128. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2018-2023) & (USD Million)
Table 129. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2024-2029) & (USD Million)
Table 130. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2018-2023) & (USD Million)
Table 131. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2024-2029) & (USD Million)
Table 132. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value By Application (2018-2023) & (USD Million)
Table 133. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value By Application (2024-2029) & (USD Million)
Table 134. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2018-2023) & (USD Million)
Table 135. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2024-2029) & (USD Million)
Table 136. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2018-2023) & (USD Million)
Table 137. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2024-2029) & (USD Million)
Table 138. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value By Application (2018-2023) & (USD Million)
Table 139. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value By Application (2024-2029) & (USD Million)
Table 140. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2018-2023) & (USD Million)
Table 141. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2024-2029) & (USD Million)
Table 142. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2018-2023) & (USD Million)
Table 143. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2024-2029) & (USD Million)
Table 144. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value By Application (2018-2023) & (USD Million)
Table 145. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value By Application (2024-2029) & (USD Million)
Table 146. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2018-2023) & (USD Million)
Table 147. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2024-2029) & (USD Million)
Table 148. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2018-2023) & (USD Million)
Table 149. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2024-2029) & (USD Million)
Table 150. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value By Application (2018-2023) & (USD Million)
Table 151. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value By Application (2024-2029) & (USD Million)
Table 152. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2018-2023) & (USD Million)
Table 153. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2024-2029) & (USD Million)
Table 154. Cell and Gene Therapy Supply Chain and Logistics Raw Material
Table 155. Key Suppliers of Cell and Gene Therapy Supply Chain and Logistics Raw Materials
LIST OF FIGURES
Figure 1. Cell and Gene Therapy Supply Chain and Logistics Picture
Figure 2. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type in 2022
Figure 4. Ordering and Scheduling Services
Figure 5. Sample Collection Services
Figure 6. Logistics Services
Figure 7. Post Treatment Follow-Up Services
Figure 8. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share By Application in 2022
Figure 10. Biobank Picture
Figure 11. Cell Therapy Lab Picture
Figure 12. Hospital Picture
Figure 13. Research Institute Picture
Figure 14. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Cell and Gene Therapy Supply Chain and Logistics Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Region in 2022
Figure 19. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Players in 2022
Figure 25. Cell and Gene Therapy Supply Chain and Logistics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Cell and Gene Therapy Supply Chain and Logistics Market Share in 2022
Figure 27. Global Top 6 Players Cell and Gene Therapy Supply Chain and Logistics Market Share in 2022
Figure 28. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Share by Type (2018-2023)
Figure 29. Global Cell and Gene Therapy Supply Chain and Logistics Market Share Forecast by Type (2024-2029)
Figure 30. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Share By Application (2018-2023)
Figure 31. Global Cell and Gene Therapy Supply Chain and Logistics Market Share Forecast By Application (2024-2029)
Figure 32. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share By Application (2018-2029)
Figure 34. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share By Application (2018-2029)
Figure 40. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 42. France Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share By Application (2018-2029)
Figure 48. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Region (2018-2029)
Figure 49. China Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 52. India Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share By Application (2018-2029)
Figure 57. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share By Application (2018-2029)
Figure 62. Middle East and Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 66. Cell and Gene Therapy Supply Chain and Logistics Market Drivers
Figure 67. Cell and Gene Therapy Supply Chain and Logistics Market Restraints
Figure 68. Cell and Gene Therapy Supply Chain and Logistics Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Cell and Gene Therapy Supply Chain and Logistics in 2022
Figure 71. Manufacturing Process Analysis of Cell and Gene Therapy Supply Chain and Logistics
Figure 72. Cell and Gene Therapy Supply Chain and Logistics Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. Cell and Gene Therapy Supply Chain and Logistics Picture
Figure 2. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type in 2022
Figure 4. Ordering and Scheduling Services
Figure 5. Sample Collection Services
Figure 6. Logistics Services
Figure 7. Post Treatment Follow-Up Services
Figure 8. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share By Application in 2022
Figure 10. Biobank Picture
Figure 11. Cell Therapy Lab Picture
Figure 12. Hospital Picture
Figure 13. Research Institute Picture
Figure 14. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Cell and Gene Therapy Supply Chain and Logistics Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Region in 2022
Figure 19. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Players in 2022
Figure 25. Cell and Gene Therapy Supply Chain and Logistics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Cell and Gene Therapy Supply Chain and Logistics Market Share in 2022
Figure 27. Global Top 6 Players Cell and Gene Therapy Supply Chain and Logistics Market Share in 2022
Figure 28. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Share by Type (2018-2023)
Figure 29. Global Cell and Gene Therapy Supply Chain and Logistics Market Share Forecast by Type (2024-2029)
Figure 30. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Share By Application (2018-2023)
Figure 31. Global Cell and Gene Therapy Supply Chain and Logistics Market Share Forecast By Application (2024-2029)
Figure 32. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share By Application (2018-2029)
Figure 34. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share By Application (2018-2029)
Figure 40. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 42. France Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share By Application (2018-2029)
Figure 48. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Region (2018-2029)
Figure 49. China Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 52. India Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share By Application (2018-2029)
Figure 57. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share By Application (2018-2029)
Figure 62. Middle East and Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 66. Cell and Gene Therapy Supply Chain and Logistics Market Drivers
Figure 67. Cell and Gene Therapy Supply Chain and Logistics Market Restraints
Figure 68. Cell and Gene Therapy Supply Chain and Logistics Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Cell and Gene Therapy Supply Chain and Logistics in 2022
Figure 71. Manufacturing Process Analysis of Cell and Gene Therapy Supply Chain and Logistics
Figure 72. Cell and Gene Therapy Supply Chain and Logistics Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
